Table 5.
Disease Free Survival | Disease Specific Survival | |||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | |
Patient Characteristics | ||||||
Age | 1.01 | 0.99, 1.03 | 0.2 | 1.01 | 0.98, 1.03 | 0.61 |
Race | * | * | * | 0.8 | 0.38, 1.68 | 0.56 |
Radiation therapyµ | 0.19 | 0.11, 0.34 | <0.001 | 0.33 | 0.19, 0.6 | <0.001 |
Serum platelet level | 2.24 | 1.26, 3.98 | <0.01 | 1.03 | 0.56, 1.88 | 0.93 |
Serum CA-125 level | 1.00 | 1.00, 1.00 | 0.001 | 1.001 | 1.000, 1.001 | 0.014 |
Tumor Characteristics | ||||||
Stage | 1.54 | 0.89, 2.65 | 0.12 | 1.35 | 0.76, 2.42 | 0.31 |
Grade | 5.13 | 1.59, 16.67 | <0.01 | 8.29 | 2.01, 4.25 | <0.01 |
LVSI | 1.72 | 0.78, 3.80 | 0.18 | 1.27 | 0.63, 2.56 | 0.5 |
Only those variables significant in univariate analysis are included
no data presented because not included in analysis.
Includes EBRT, vaginal brachytherapy, or a combination of both